PrairieGold Venture Partners

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 18
Average round size
info
The average size of a deal this fund participated in
$10M
Portfolio companies 7
Lead investments 3
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.61
Exits 3
Key employees 2
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Biotechnology
  • Health Diagnostics
  • Genetics
  • Robotics
Summary

The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the Sioux Falls.

We also calculated 2 valuable employees in our database.

Speaking about the real fund results, this VC is 2 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. This PrairieGold Venture Partners works on 23 percentage points less the average amount of lead investments comparing to the other organizations. The important activity for fund was in 2012. Deals in the range of 5 - 10 millions dollars are the general things for fund.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Medical Device, Advanced Materials. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Lineagen, Agrivida, ZeaChem. The fund has no exact preference in some founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the PrairieGold Venture Partners, startups are often financed by Sanderling Ventures, Mesa Verde Venture Partners, vSpring Capital. The meaningful sponsors for the fund in investment in the same round are Bluestem Capital, Sanderling Ventures, Mesa Verde Venture Partners. In the next rounds fund is usually obtained by Northgate Capital, Kleiner Perkins, Sanderling Ventures.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of PrairieGold Venture Partners:
Typical Co-investors
PrairieGold Venture Partners is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after PrairieGold Venture Partners:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aurora UV California, Santa Barbara, United States
Barclays Ventures England, London, United Kingdom
Everplus Capital California, Newport Beach, United States
Greener House Investments Surrey, United Kingdom, Woking
Jiangdong Holding Group -
Leap Venture Studio California, Los Angeles, United States
Olympus Japan, Tokyo
Sherpa Partners Minnesota, Saint Louis Park, United States
Sino-Ocean Land New York, New York, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Virtual Incision

Advanced Materials
Developer Platform
Health Care
Robotics
$20M08 Jan 2020 Lincoln, Nebraska, United States

Virtual Incision

Advanced Materials
Developer Platform
Health Care
Robotics
$18M12 Dec 2017 Lincoln, Nebraska, United States

Virtual Incision

Advanced Materials
Developer Platform
Health Care
Robotics
$11M06 Aug 2015 Lincoln, Nebraska, United States

Lineagen

Biotechnology
Genetics
Health Care
Health Diagnostics
$12M26 Jan 2015 Salt Lake City, Utah, United States

Agrivida

Biofuel
Biomass Energy
Biotechnology
$12M05 Jan 2015 Cambridge, Massachusetts, United States

Lineagen

Biotechnology
Genetics
Health Care
Health Diagnostics
$3M18 Dec 2013 Salt Lake City, Utah, United States

Chronix Biomedical

Biotechnology
Health Diagnostics
Medical
$1M31 Oct 2012 San Jose, California, United States

Agrivida

Biofuel
Biomass Energy
Biotechnology
$15M12 Sep 2012 Cambridge, Massachusetts, United States

ZeaChem

Chemical
Fuel
Renewable Energy
$19M14 Feb 2012 Lakewood, Colorado, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent PrairieGold Venture Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: